SRINAGAR — With the approval of influenza drug Molnupiravir for Covid-19 patients, Doctors Association Kashmir (DAK) on Wednesday said the drug reduces the risk of hospitalization and death in Covid patients. “Molnupiravir prevents death in Covid patients when given early in the course of illness,” said DAK President and Influenza expert Dr Nisar ul Hassan. […]
